Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE)
Clinical trial NCT06011798 · COMPLETED
Trial details
- NCT number
- NCT06011798
- Sponsor
- Unity Biotechnology, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-23
- Primary completion
- 2025-01-21
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.